Thermo Fisher Scientific Inc.
TMO 515.98 (-0.11%) 0.55
Health Care
Life Sciences Tools and Services
Quality Checklist 6/8
5Y Shares Out Change < 0%
Debt/Equity < 1
Current Ratio > 1
Quick Ratio > 1
Net Margin > 10%
Est. EPS Growth > 5%
ROIC > 10%
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $193.86(B)
EV: $226.77(B)
Total Equity: $53.54(B)
Earnings date: Apr-22-2026
P/E: 29.02
Forward P/E: 21.03
P/FCF: 30.82
P/S: 4.37
P/B: 3.63
EPS: $17.8
EPS (fwd): $24.5
FCF/share: $16.7
Revenue/share: $118.2
Book value/share: $142.1
ROIC: 7.7%
ROA: 6.5%
ROE: 13.1%
Debt/Equity: 0.74
Current Ratio: 1.90
Gross margin: 41.7%
Operating margin: 18.4%
Net margin: 15.0%
Dividend/share: $1.7
Div. yield: 0.33%
TTM Financials
Income (TTM)
Revenue$44.56(B)
Gross profit$18.57(B)
EBITDA$11.15(B)
Net income$6.70(B)
Gross margin41.7%
Operating margin18.4%
Net margin15.0%
Shares outstanding375.71(M)
Balance sheet
Total assets$110.34(B)
Current assets$28.71(B)
Total liabilities$56.81(B)
Current liabilities$15.19(B)
Cash & Short-term inv.$10.11(B)
Long-term debt$35.85(B)
Total intangibles$65.20(B)
PP&E$10.56(B)
Cash flow (TTM)
FCF$6.29(B)
CapEx$-1.52(B)
Dividends paid$-636.00(M)
Stock issued$0
Stock repurchased$-3.00(B)
Stock-based comp.$305.00(M)
Debt issued$8.85(B)
Debt repaid$-3.51(B)